Funakoshi A, Morikawa T, Muramatsu R, Yagi K, Seino M
National Epilepsy Center, Shizuoka Higashi Hospital.
Jpn J Psychiatry Neurol. 1988 Sep;42(3):562-4. doi: 10.1111/j.1440-1819.1988.tb01357.x.
A prospective intraindividual study of WISC-R testing in the 45 children with epilepsy revealed that: 1) antiepileptic drugs, phenobarbital in particular, resulted in a detrimental effect on the WISC-R scores, 2) of the WISC-R subtests, vocabulary tasks of the verbal test were the most susceptible indicators in children whose FSIQ scores either improved or deteriorated, and 3) in children whose antiepileptic drug dosage remained unchanged while the seizure frequency remained unchanged, both the VIQ and PIQ scores decreased. It was evident that either recurrent seizures or inappropriate medication may exert a detrimental effect on intelligence as expressed by the WISC-R testing. In addition, the possibility that the underlying cerebral pathology associated with the etiology of epilepsy may play a role in a progressive intellectual deterioration was suggested.
一项针对45名癫痫患儿进行的韦氏儿童智力量表修订版(WISC-R)测试的前瞻性个体内研究表明:1)抗癫痫药物,尤其是苯巴比妥,会对WISC-R分数产生不利影响;2)在WISC-R子测试中,言语测试的词汇任务是FSIQ分数提高或降低的儿童中最敏感的指标;3)在抗癫痫药物剂量不变而癫痫发作频率不变的儿童中,言语智商(VIQ)和操作智商(PIQ)分数均下降。很明显,复发性癫痫发作或不适当的药物治疗可能会对WISC-R测试所表达的智力产生不利影响。此外,还提示与癫痫病因相关的潜在脑部病变可能在进行性智力衰退中起作用。